By creator to www.digitaljournal.com
SAN JOSE, Calif.–(Enterprise Wire)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical expertise firm pioneering a first-of-its-kind gadget to scale back the associated fee and complexity of dialysis, is bolstering its board of administrators with the appointment of Karen Drexler. Drexler at present serves on the boards of ResMed (NYSE: RMD), a $31B data-driven sleep and respiratory market chief; VIDA Diagnostics, developer of AI-powered lung intelligence and imaging options; and Tivic Well being, a bioelectronic drugs firm. Named one among Ladies Inc. journal’s most influential company administrators in 2018, Drexler brings to Outset a deep understanding of the right way to make the most of knowledge analytics and machine studying to energy the consumer expertise, whereas supporting the affected person at residence and within the hospital setting.
“Karen’s expertise within the medtech area, utilizing knowledge analytics and a consumer-centric strategy to creating a greater affected person expertise, aligns fantastically with the business methods we’re implementing each within the residence and the acute markets with Tablo,” stated Outset Medical CEO Leslie Trigg. “She brings a brand new perspective and invaluable information that can assist gasoline our speedy progress trajectory.”
Drexler brings intensive technical and operational management to her function on the Outset board. Most not too long ago, she was the CEO of Sandstone Diagnostics, a life science instruments firm targeted on elevated entry to high-quality diagnostic testing. Previous to that, she based and served as CEO at Amira Medical till its sale to Roche Diabetes Care. Drexler began her profession at LifeScan the place she managed a wide range of capabilities and finally executed the sale of the corporate to Johnson & Johnson.
“Over the course of my profession I’ve labored with a wide range of private and non-private medical gadget and diagnostics firms to search out options for persistent illness administration, all with the objective of making higher affected person experiences and outcomes,” stated Drexler. “From my very straight associated expertise working to enhance life for individuals with diabetes, to how AI can modernize scientific diagnostics and therapeutic options, I’m fascinated by firms that make the most of expertise to make sufferers’ lives higher. Outset’s Tablo System reduces the burden of persistent kidney take care of suppliers, sufferers and caregivers, displaying how all stakeholders can win with the optimum use of expertise and patient-centered designs.”
Outset additionally introduced as we speak that TJ Carella, head of healthcare at Warburg Pincus, which first invested within the firm greater than 10 years in the past, has stepped off the board.
“TJ has been instrumental in supporting our efforts to scale the group and obtain U.S. business success,” added Trigg. “His insights, and dedication to creating an influence on the renal trade, helped us get to the place we’re as we speak.”
About Outset Medical
Outset is a medical expertise firm pioneering a first-of-its-kind expertise to scale back the associated fee and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared to be used from the hospital to the house, represents a big technological development that transforms the dialysis expertise for sufferers and operationally simplifies it for suppliers. Tablo serves as a single enterprise resolution that may be utilized throughout the continuum of care, permitting dialysis to be delivered anytime, wherever and by anybody. The mixing of water purification and on-demand dialysate manufacturing permits Tablo to function a dialysis clinic on wheels, with 2-way wi-fi knowledge transmission and a proprietary knowledge analytics platform powering a brand new holistic strategy to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
Lynn Lewis or Brian Johnston